Trial record 2 of 8 for:
orphazyme
Arimoclomol in Sporadic Inclusion Body Myositis - Open Label Extension Trial
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT04049097 |
Recruitment Status :
Enrolling by invitation
First Posted : August 7, 2019
Last Update Posted : November 12, 2020
|
Sponsor:
Orphazyme
Collaborators:
University of Kansas Medical Center
University College, London
Information provided by (Responsible Party):
Orphazyme
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : | Enrolling by invitation |
---|---|
Estimated Primary Completion Date : | May 22, 2022 |
Estimated Study Completion Date : | May 22, 2022 |